Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 17 de 17
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Int J Mol Sci ; 23(7)2022 Mar 30.
Artigo em Inglês | MEDLINE | ID: mdl-35409168

RESUMO

The etiopathogenesis of obesity-related chronic kidney disease (CKD) is still scarcely understood. To this aim, we assessed the effect of high-fat diet (HF) on molecular pathways leading to organ damage, steatosis, and fibrosis. Six-week-old male C57BL/6N mice were fed HF diet or normal chow for 20 weeks. Kidneys were collected for genomic, proteomic, histological studies, and lipid quantification. The main findings were as follows: (1) HF diet activated specific pathways leading to fibrosis and increased fatty acid metabolism; (2) HF diet promoted a metabolic shift of lipid metabolism from peroxisomes to mitochondria; (3) no signs of lipid accumulation and/or fibrosis were observed, histologically; (4) the early signs of kidney damage seemed to be related to changes in membrane protein expression; (5) the proto-oncogene MYC was one of the upstream transcriptional regulators of changes occurring in protein expression. These results demonstrated the potential usefulness of specific selected molecules as early markers of renal injury in HF, while histomorphological changes become visible later in obesity-related CDK. The integration of these information with data from biological fluids could help the identification of biomarkers useful for the early detection and prevention of tissue damage in clinical practice.


Assuntos
Dieta Hiperlipídica , Insuficiência Renal Crônica , Animais , Biomarcadores/metabolismo , Dieta Hiperlipídica/efeitos adversos , Fibrose , Rim/metabolismo , Lipídeos , Fígado/metabolismo , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Obesidade/metabolismo , Proteoma/metabolismo , Proteômica , Insuficiência Renal Crônica/metabolismo
2.
Biochem Biophys Res Commun ; 577: 89-94, 2021 11 05.
Artigo em Inglês | MEDLINE | ID: mdl-34509083

RESUMO

The protozoan Plasmodium falciparum is the main aetiological agent of tropical malaria. Characteristic of the phylum is the presence of a plastid-like organelle which hosts several homologs of plant proteins, including a ferredoxin (PfFd) and its NADPH-dependent reductase (PfFNR). The PfFNR/PfFd redox system is essential for the parasite, while mammals share no homologous proteins, making the enzyme an attractive target for novel and much needed antimalarial drugs. Based on previous findings, three chemically reactive residues important for PfFNR activity were identified: namely, the active-site Cys99, responsible for hydride transfer; Cys284, whose oxidation leads to an inactive dimeric form of the protein; and His286, which is involved in NADPH binding. These amino acid residues were probed by several residue-specific reagents and the two cysteines were shown to be promising targets for covalent inhibition. The quantitative and qualitative description of the reactivity of few compounds, including a repurposed drug, set the bases for the development of more potent and specific antimalarial leads.


Assuntos
Inibidores Enzimáticos/farmacologia , Ferredoxina-NADP Redutase/antagonistas & inibidores , Malária Falciparum/prevenção & controle , Plasmodium falciparum/efeitos dos fármacos , Proteínas de Protozoários/antagonistas & inibidores , Antineoplásicos Alquilantes/química , Antineoplásicos Alquilantes/metabolismo , Antineoplásicos Alquilantes/farmacologia , Biocatálise/efeitos dos fármacos , Carmustina/química , Carmustina/metabolismo , Carmustina/farmacologia , Domínio Catalítico , Cisteína/química , Cisteína/metabolismo , Diamida/química , Diamida/metabolismo , Diamida/farmacologia , Inibidores Enzimáticos/química , Inibidores Enzimáticos/metabolismo , Ferredoxina-NADP Redutase/química , Ferredoxina-NADP Redutase/metabolismo , Cinética , Malária Falciparum/parasitologia , Estrutura Molecular , NADP/metabolismo , Compostos Organomercúricos/química , Compostos Organomercúricos/metabolismo , Compostos Organomercúricos/farmacologia , Plasmodium falciparum/enzimologia , Plasmodium falciparum/fisiologia , Ligação Proteica , Domínios Proteicos , Proteínas de Protozoários/química , Proteínas de Protozoários/metabolismo , Especificidade por Substrato
3.
Sci Rep ; 11(1): 8339, 2021 04 16.
Artigo em Inglês | MEDLINE | ID: mdl-33863921

RESUMO

The amyloidoses constitute a group of diseases occurring in humans and animals that are characterized by abnormal deposits of aggregated proteins in organs, affecting their structure and function. In the Abyssinian cat breed, a familial form of renal amyloidosis has been described. In this study, multi-omics analyses were applied and integrated to explore some aspects of the unknown pathogenetic processes in cats. Whole-genome sequences of two affected Abyssinians and 195 controls of other breeds (part of the 99 Lives initiative) were screened to prioritize potential disease-associated variants. Proteome and miRNAome from formalin-fixed paraffin-embedded kidney specimens of fully necropsied Abyssinian cats, three affected and three non-amyloidosis-affected were characterized. While the trigger of the disorder remains unclear, overall, (i) 35,960 genomic variants were detected; (ii) 215 and 56 proteins were identified as exclusive or overexpressed in the affected and control kidneys, respectively; (iii) 60 miRNAs were differentially expressed, 20 of which are newly described. With omics data integration, the general conclusions are: (i) the familial amyloid renal form in Abyssinians is not a simple monogenic trait; (ii) amyloid deposition is not triggered by mutated amyloidogenic proteins but is a mix of proteins codified by wild-type genes; (iii) the form is biochemically classifiable as AA amyloidosis.


Assuntos
Proteínas Amiloidogênicas/metabolismo , Amiloidose Familiar/genética , Amiloidose Familiar/veterinária , Doenças do Gato/genética , Doenças do Gato/metabolismo , Gatos/genética , Gatos/metabolismo , Nefropatias/genética , Nefropatias/veterinária , Rim/metabolismo , Amiloidose Familiar/metabolismo , Animais , Variação Genética/genética , Nefropatias/metabolismo , MicroRNAs , Proteômica , Sequenciamento Completo do Genoma
4.
Cells ; 9(11)2020 11 16.
Artigo em Inglês | MEDLINE | ID: mdl-33207837

RESUMO

Liver cancer is one of the most common cancer worldwide with a high mortality. Methionine is an essential amino acid required for normal development and cell growth, is mainly metabolized in the liver, and its role as an anti-cancer supplement is still controversial. Here, we evaluate the effects of methionine supplementation in liver cancer cells. An integrative proteomic and metabolomic analysis indicates a rewiring of the central carbon metabolism, with an upregulation of the tricarboxylic acid (TCA) cycle and mitochondrial adenosine triphosphate (ATP) production in the presence of high methionine and AMP-activated protein kinase (AMPK) inhibition. Methionine supplementation also reduces growth rate in liver cancer cells and induces the activation of both the AMPK and mTOR pathways. Interestingly, in high methionine concentration, inhibition of AMPK strongly impairs cell growth, cell migration, and colony formation, indicating the main role of AMPK in the control of liver cancer phenotypes. Therefore, regulation of methionine in the diet combined with AMPK inhibition could reduce liver cancer progression.


Assuntos
Proteínas Quinases Ativadas por AMP/metabolismo , Neoplasias Hepáticas/metabolismo , Neoplasias Hepáticas/patologia , Metionina/farmacologia , Trifosfato de Adenosina/metabolismo , Proliferação de Células/efeitos dos fármacos , Células Hep G2 , Humanos , Neoplasias Hepáticas/tratamento farmacológico , Metionina/metabolismo , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/metabolismo , Transdução de Sinais/efeitos dos fármacos , Serina-Treonina Quinases TOR/efeitos dos fármacos , Serina-Treonina Quinases TOR/metabolismo
5.
Aging (Albany NY) ; 12(19): 19785-19808, 2020 Oct 05.
Artigo em Inglês | MEDLINE | ID: mdl-33024055

RESUMO

Aging and age-related neurodegeneration are among the major challenges in modern medicine because of the progressive increase in the number of elderly in the world population. Nutrition, which has important long-term consequences for health, is an important way to prevent diseases and achieve healthy aging. The beneficial effects of Vigna unguiculata on metabolic disorders have been widely documented. Here, we show that an aqueous extract of V. unguiculata beans delays senescence both in Saccharomyces cerevisiae and Drosophila melanogaster, in a Snf1/AMPK-dependent manner. Consistently, an increased expression of FOXO, SIRT1, NOTCH and heme oxygenase (HO) genes, already known to be required for the longevity extension in D. melanogaster, is also shown. Preventing α-synuclein self-assembly is one of the most promising approaches for the treatment of Parkinson's disease (PD), for which aging is a risk factor. In vitro aggregation of α-synuclein, its toxicity and membrane localization in yeast and neuroblastoma cells are strongly decreased in the presence of bean extract. In a Caenorhabditis elegans model of PD, V. unguiculata extract substantially reduces the number of the age-dependent degeneration of the cephalic dopaminergic neurons. Our findings support the role of V. unguiculata beans as a functional food in age-related disorders.

6.
Food Funct ; 11(7): 5853-5865, 2020 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-32589172

RESUMO

Colorectal cancer (CRC) is one of the most common types of cancer, especially in Western countries, and its incidence rate is increasing every year. In this study, for the first time Vigna unguiculata L. Walp. (cowpea) water boiled seed extracts were found to reduce the viability of different colorectal cancer (CRC) cell lines, such as E705, DiFi and SW480 and the proliferation of Caco-2 line too, without affecting CCD841 healthy cell line. Furthermore, the extracts showed the ability to reduce the level of Epidermal Growth Factor Receptor (EGFR) phosphorylation in E705, DiFi and SW480 cell lines and to lower the EC50 of a CRC common drug, cetuximab, on E705 and DiFi lines from 161.7 ng mL-1 to 0.06 ng mL-1 and from 49.5 ng mL-1 to 0.2 ng mL-1 respectively. The extract was characterized in its protein and metabolite profiles by tandem mass spectrometry and 1H-NMR analyses. A Bowman-Birk protease inhibitor was identified within the protein fraction and was supposed to be the main active component. These findings confirm the importance of a legume-based diet to prevent the outbreak of many CRC and to reduce the amount of drug administered during a therapeutic cycle.


Assuntos
Antineoplásicos Fitogênicos/uso terapêutico , Neoplasias Colorretais/tratamento farmacológico , Fitoterapia , Extratos Vegetais/uso terapêutico , Inibidores de Proteases/uso terapêutico , Sementes/química , Vigna/química , Antineoplásicos Fitogênicos/farmacologia , Células CACO-2 , Linhagem Celular Tumoral , Sobrevivência Celular , Cetuximab , Neoplasias Colorretais/prevenção & controle , Receptores ErbB/metabolismo , Humanos , Fosforilação , Extratos Vegetais/farmacologia , Proteínas de Plantas/farmacologia , Proteínas de Plantas/uso terapêutico , Inibidores de Proteases/farmacologia
7.
J Proteomics ; 166: 115-126, 2017 08 23.
Artigo em Inglês | MEDLINE | ID: mdl-28739509

RESUMO

Mesenchymal stem cells (MSC) represent an impressive opportunity in term of regenerative medicine and immunosuppressive therapy. Although it is clear that upon transplantation MSC exert most of their therapeutic effects through the secretion of bioactive molecules, the effects of a pro-inflammatory recipient environment on MSC secretome have not been characterized. In this study, we used a label free mass spectrometry based quantitative proteomic approach to analyze how pro-inflammatory cytokines modulate the composition of the human MSC secretome. We found that pro-inflammatory cytokines have a strong impact on the secretome of human bone marrow-derived MSC and that the large majority of cytokine-induced proteins are involved in inflammation and/or angiogenesis. Comparative analyses with results recently obtained on mouse MSC secretome stimulated under the same conditions reveals both analogies and differences in the effect of pro-inflammatory cytokines on MSC secretome in the two organisms. In particular, functional analyses confirmed that tissue inhibitor of metalloproteinase-1 (TIMP1) is a key effector molecule responsible for the anti-angiogenic properties of both human and mouse MSC within an inflammatory microenvironment. Mass spectrometry data are available via ProteomeXchange with identifier PXD005746 SIGNIFICANCE: The secretion of a broad range of bioactive molecules is believed to be the main mechanism by which MSC exert specific therapeutic effects. MSC are very versatile and respond to specific environments by producing and releasing a variety of effector molecules. To the best of our knowledge this is the first study aimed at describing the secretome of human MSC primed using a mixture of cytokines, to mimic pro-inflammatory conditions encountered in vivo, by a quantitative high-resolution mass spectrometry based approach. The main output of the study concerns the identification of a list of specific proteins involved in inflammation and angiogenesis which are overrepresented in stimulated MSC secretome. The data complement a previous study on the secretome of mouse MSC stimulated under the same conditions. Comparative analyses reveal analogies and differences in the biological processes affected by overrepresented proteins in the two organisms. In particular, the key role of TIMP-1 for the anti-angiogenic properties of stimulated MSC secretome already observed in mouse is confirmed in human. Overall, these studies represent key steps necessary to characterize the different biology of MSC in the two organisms and design successful pre-clinical experiments as well as clinical trials.


Assuntos
Citocinas/farmacologia , Células-Tronco Mesenquimais/metabolismo , Inibidor Tecidual de Metaloproteinase-1/fisiologia , Indutores da Angiogênese , Animais , Humanos , Inflamação/metabolismo , Espectrometria de Massas , Células-Tronco Mesenquimais/efeitos dos fármacos , Camundongos , Proteômica/métodos
8.
J Biol Chem ; 290(41): 24715-26, 2015 Oct 09.
Artigo em Inglês | MEDLINE | ID: mdl-26309257

RESUMO

In eukaryotes, nutrient availability and metabolism are coordinated by sensing mechanisms and signaling pathways, which influence a broad set of cellular functions such as transcription and metabolic pathways to match environmental conditions. In yeast, PKA is activated in the presence of high glucose concentrations, favoring fast nutrient utilization, shutting down stress responses, and boosting growth. On the contrary, Snf1/AMPK is activated in the presence of low glucose or alternative carbon sources, thus promoting an energy saving program through transcriptional activation and phosphorylation of metabolic enzymes. The PKA and Snf1/AMPK pathways share common downstream targets. Moreover, PKA has been reported to negatively influence the activation of Snf1/AMPK. We report a new cross-talk mechanism with a Snf1-dependent regulation of the PKA pathway. We show that Snf1 and adenylate cyclase (Cyr1) interact in a nutrient-independent manner. Moreover, we identify Cyr1 as a Snf1 substrate and show that Snf1 activation state influences Cyr1 phosphorylation pattern, cAMP intracellular levels, and PKA-dependent transcription.


Assuntos
Proteínas Quinases Dependentes de AMP Cíclico/metabolismo , Proteínas Mitocondriais/metabolismo , Proteínas Serina-Treonina Quinases/metabolismo , Proteínas de Saccharomyces cerevisiae/metabolismo , Saccharomyces cerevisiae/genética , Saccharomyces cerevisiae/metabolismo , Transcrição Gênica , Proteínas Quinases Ativadas por AMP/metabolismo , Biocatálise , Ativação Enzimática/efeitos dos fármacos , Regulação Fúngica da Expressão Gênica/efeitos dos fármacos , Glucose/farmacologia , Mutação , Fenótipo , Fosforilação/efeitos dos fármacos , Proteínas Serina-Treonina Quinases/genética , Estrutura Terciária de Proteína , Saccharomyces cerevisiae/efeitos dos fármacos , Saccharomyces cerevisiae/enzimologia , Transcrição Gênica/efeitos dos fármacos
9.
Glycobiology ; 25(8): 855-68, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-25922362

RESUMO

Several studies performed over the last decade have focused on the role of sialylation in the progression of cancer and, in particular, on the association between deregulation of sialidases and tumorigenic transformation. The plasma membrane-associated sialidase NEU3 is often deregulated in colorectal cancer (CRC), and it was shown that this enzyme co-immunoprecipitates in HeLa cells with epidermal growth factor receptor (EGFR), the molecular target of most recent monoclonal antibody-based therapies against CRC. To investigate the role of NEU3 sialidase on EGFR deregulation in CRC, we first collected data on NEU3 gene expression levels from a library of commercial colon cell lines, demonstrating that NEU3 transcription is upregulated in these cell lines. We also found EGFR to be hyperphosphorylated in all cell lines, with the exception of SW620 cells and the CCD841 normal intestinal cell line. By comparing the effects induced by overexpression of either the wild-type or the inactive mutant form of NEU3 on EGFR, we demonstrated that the active form of NEU3 enhanced receptor activation without affecting EGFR mRNA or protein expression. Moreover, through western blots and mass spectrometry analysis, we found that EGFR immunoprecipitated from cells overexpressing active NEU3, unlike the receptor from mock cells and cells overexpressing inactive NEU3, is desialylated. On the whole, our data demonstrate that, besides the already reported indirect EGFR activation through GM3, sialidase NEU3 could also play a role on EGFR activation through its desialylation.


Assuntos
Células Epiteliais/metabolismo , Receptores ErbB/genética , Regulação Neoplásica da Expressão Gênica , Proteínas de Neoplasias/genética , Neuraminidase/genética , Processamento de Proteína Pós-Traducional , Linhagem Celular Tumoral , Membrana Celular , Colo/metabolismo , Colo/patologia , Células Epiteliais/patologia , Receptores ErbB/metabolismo , Gangliosídeo G(M3)/metabolismo , Humanos , Modelos Moleculares , Proteínas de Neoplasias/metabolismo , Neuraminidase/metabolismo , Fosforilação , Ácidos Siálicos/metabolismo , Transdução de Sinais , Transcrição Gênica
10.
J Nanobiotechnology ; 11: 35, 2013 Oct 11.
Artigo em Inglês | MEDLINE | ID: mdl-24119372

RESUMO

BACKGROUND: Substrate nanoscale topography influences cell proliferation and differentiation through mechanisms that are at present poorly understood. In particular the molecular mechanism through which cells 'sense' and adapt to the substrate and activate specific intracellular signals, influencing cells survival and behavior, remains to be clarified. RESULTS: To characterize these processes at the molecular level we studied the differentiation of PC12 cells on nanostructured TiO2 films obtained by supersonic cluster beam deposition.Our findings indicate that, in PC12 cells grown without Nerve Growth Factor (NGF), the roughness of nanostructured TiO2 triggers neuritogenesis by activating the expression of nitric oxide synthase (NOS) and the phospho-extracellular signal-regulated kinase 1/2 (pERK1/2) signaling. Differentiation is associated with an increase in protein nitration as observed in PC12 cells grown on flat surfaces in the presence of NGF. We demonstrate that cell differentiation and protein nitration induced by topography are not specific for PC12 cells but can be regarded as generalized effects produced by the substrate on different neuronal-like cell types, as shown by growing the human neuroblastoma SH-SY5Y cell line on nanostructured TiO2. CONCLUSION: Our data provide the evidence that the nitric oxide (NO) signal cascade is involved in the differentiation process induced by nanotopography, adding new information on the mechanism and proteins involved in the neuritogenesis triggered by the surface properties.


Assuntos
Materiais Biocompatíveis/química , Mecanotransdução Celular , Óxido Nítrico Sintase Tipo II/metabolismo , Óxido Nítrico/metabolismo , Titânio/química , Animais , Materiais Biocompatíveis/farmacologia , Diferenciação Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Regulação da Expressão Gênica , Humanos , Proteína Quinase 1 Ativada por Mitógeno/genética , Proteína Quinase 1 Ativada por Mitógeno/metabolismo , Proteína Quinase 3 Ativada por Mitógeno/genética , Proteína Quinase 3 Ativada por Mitógeno/metabolismo , Fator de Crescimento Neural/farmacologia , Neuritos/metabolismo , Neuritos/ultraestrutura , Óxido Nítrico Sintase Tipo II/genética , Células PC12 , Ratos , Propriedades de Superfície , Titânio/farmacologia , Tirosina/análogos & derivados , Tirosina/metabolismo
11.
Cell Biol Int ; 35(3): 249-58, 2011 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-20946105

RESUMO

Numerous studies indicate that microgravity affects cell growth and differentiation in many living organisms, and various processes are modified when cells are placed under conditions of weightlessness. However, until now, there is no coherent explanation for these observations, and little information is available concerning the biomolecules involved. Our aim has been to investigate the protein pattern of Xenopus laevis embryos exposed to simulated microgravity during the first 6 days of development. A proteomic approach was applied to compare the protein profiles of Xenopus embryos developed in simulated microgravity and in normal conditions. Attention was focused on embryos that do not present visible malformations in order to investigate if weightlessness has effects at protein level in the absence of macroscopic alterations. The data presented strongly suggest that some of the major components of the cytoskeleton vary in such conditions. Three major findings are described for the first time: (i) the expression of important factors involved in the organization and stabilization of the cytoskeleton, such as Arp (actin-related protein) 3 and stathmin, is heavily affected by microgravity; (ii) the amount of the two major cytoskeletal proteins, actin and tubulin, do not change in such conditions; however, (iii) an increase in the tyrosine nitration of these two proteins can be detected. The data suggest that, in the absence of morphological alterations, simulated microgravity affects the intracellular movement system of cells by altering cytoskeletal proteins heavily involved in the regulation of cytoskeleton remodelling.


Assuntos
Proteínas do Citoesqueleto/metabolismo , Embrião não Mamífero/metabolismo , Proteínas de Xenopus/metabolismo , Proteína 3 Relacionada a Actina/metabolismo , Actinas/metabolismo , Animais , Eletroforese em Gel Bidimensional , Desenvolvimento Embrionário , Nitratos/química , Nitratos/metabolismo , Fosforilação , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz , Estatmina/metabolismo , Tubulina (Proteína)/metabolismo , Tirosina/metabolismo , Ausência de Peso , Simulação de Ausência de Peso , Xenopus laevis
13.
J Mol Biol ; 385(1): 140-52, 2009 Jan 09.
Artigo em Inglês | MEDLINE | ID: mdl-18976670

RESUMO

The mRNA-capping process starts with the conversion of a 5'-triphosphate end into a 5'-diphosphate by an RNA triphosphatase, followed by the addition of a guanosine monophosphate unit in a 5'-5' phosphodiester bond by a guanylyltransferase. Methyltransferases are involved in the third step of the process, transferring a methyl group from S-adenosyl-l-methionine to N7-guanine (cap 0) and to the ribose 2'OH group (cap 1) of the first RNA nucleotide; capping is essential for mRNA stability and proper replication. In the genus Flavivirus, N7-methyltransferase and 2'O-methyltransferase activities have been recently associated with the N-terminal domain of the viral NS5 protein. In order to further characterize the series of enzymatic reactions that support capping, we analyzed the crystal structures of Wesselsbron virus methyltransferase in complex with the S-adenosyl-l-methionine cofactor, S-adenosyl-l-homocysteine (the product of the methylation reaction), Sinefungin (a molecular analogue of the enzyme cofactor), and three different cap analogues (GpppG, (N7Me)GpppG, and (N7Me)GpppA). The structural results, together with those on other flaviviral methyltransferases, show that the capped RNA analogues all bind to an RNA high-affinity binding site. However, lack of specific interactions between the enzyme and the first nucleotide of the RNA chain suggests the requirement of a minimal number of nucleotides following the cap to strengthen protein/RNA interaction. Our data also show that, following incubation with guanosine triphosphate, Wesselsbron virus methyltransferase displays a guanosine monophosphate molecule covalently bound to residue Lys28, hinting at possible implications for the transfer of a guanine group to ppRNA. The structures of the Wesselsbron virus methyltransferase complexes obtained are discussed in the context of a model for N7-methyltransferase and 2'O-methyltransferase activities.


Assuntos
Flavivirus/enzimologia , Metiltransferases/química , Capuzes de RNA/metabolismo , Proteínas não Estruturais Virais/química , Adenosina/análogos & derivados , Adenosina/química , Sequência de Aminoácidos , Sítios de Ligação , Bioensaio , Cristalografia por Raios X , Guanosina Trifosfato/metabolismo , Metiltransferases/antagonistas & inibidores , Modelos Moleculares , Dados de Sequência Molecular , Fragmentos de Peptídeos , Estrutura Secundária de Proteína , Estrutura Terciária de Proteína , S-Adenosilmetionina/metabolismo , Alinhamento de Sequência , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz , Proteínas não Estruturais Virais/antagonistas & inibidores
14.
FEBS J ; 275(20): 5090-107, 2008 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-18959769

RESUMO

NAD is an important cofactor and essential molecule in all living organisms. In many eubacteria, including several pathogens, the first two steps in the de novo synthesis of NAD are catalyzed by l-aspartate oxidase (NadB) and quinolinate synthase (NadA). Despite the important role played by these two enzymes in NAD metabolism, many of their biochemical and structural properties are still largely unknown. In the present study, we cloned, overexpressed and characterized NadA and NadB from Bacillus subtilis, one of the best studied bacteria and a model organism for low-GC Gram-positive bacteria. Our data demonstrated that NadA from B. subtilis possesses a [4Fe-4S]2+ cluster, and we also identified the cysteine residues involved in the cluster binding. The [4Fe-4S]2+ cluster is coordinated by three cysteine residues (Cys110, Cys230, and Cys320) that are conserved in all the NadA sequences reported so far, suggesting a new noncanonical binding motif that, on the basis of sequence alignment studies, may be common to other quinolinate synthases from different organisms. Moreover, for the first time, it was shown that the interaction between NadA and NadB is not species-specific between B. subtilis and Escherichia coli.


Assuntos
Aminoácido Oxirredutases/química , Bacillus subtilis/enzimologia , Complexos Multienzimáticos/química , Aminoácido Oxirredutases/genética , Proteínas de Bactérias/química , Proteínas de Bactérias/genética , Sítios de Ligação , Clonagem Molecular , Sequência Conservada , Cisteína , Proteínas de Escherichia coli , Proteínas Ferro-Enxofre , Complexos Multienzimáticos/genética , Especificidade da Espécie
15.
Neurochem Res ; 33(3): 518-25, 2008 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-17768677

RESUMO

Nitration of tau protein is normally linked to neurodegeneration but, until now, no comprehensive information is available regarding tau nitration in healthy subjects. It has been previously reported that in differentiated PC12 cells, tau co-immunoprecipitated with alpha-tubulin is nitrated at tyrosine residues and that this post-translation modification doesn't impair the association of tau with the cytoskeleton. The present paper is focused on the identification of tyrosine residues endogenously modified in tau from PC12 cells and reports for the first time that tau is also nitrated in vivo in normal mouse brain and that one tyrosine is endogenously modified.


Assuntos
Química Encefálica/efeitos dos fármacos , Nitratos/metabolismo , Óxido Nítrico/farmacologia , Tirosina/metabolismo , Proteínas tau/metabolismo , Animais , Western Blotting , Eletroforese em Gel Bidimensional , Concentração de Íons de Hidrogênio , Imunoprecipitação , Isomerismo , Camundongos , Células PC12 , Ratos , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz
16.
Neurochem Res ; 32(3): 433-41, 2007 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-17268851

RESUMO

The biological implication of protein tyrosine nitration in signaling pathways triggered by nitric oxide is recently emerging. Here we report for the first time that nitrotyrosination occurs in the neural intermediate filament protein peripherin. In neuron-like PC12 cells, nitrated peripherin is associated with the cytoskeleton fraction, its level increases during the progression of NGF-induced differentiation and the nitrated protein remains closely associated with stable microtubules. Tyr 17 and Tyr 376 were identified by MALDI-TOF analyses as two specific residues endogenously nitrated. Finally, peripherin nitration is not restricted to PC12 cells but it is also present in vivo in rat brain.


Assuntos
Encéfalo/metabolismo , Proteínas de Filamentos Intermediários/química , Proteínas de Filamentos Intermediários/metabolismo , Glicoproteínas de Membrana/química , Glicoproteínas de Membrana/metabolismo , Proteínas do Tecido Nervoso/química , Proteínas do Tecido Nervoso/metabolismo , Processamento de Proteína Pós-Traducional , Tirosina/análogos & derivados , Actinas/metabolismo , Animais , Eletroforese em Gel Bidimensional , Microtúbulos/metabolismo , Células PC12 , Periferinas , Ratos , Ratos Sprague-Dawley , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz , Tirosina/metabolismo
17.
FEBS Lett ; 562(1-3): 35-9, 2004 Mar 26.
Artigo em Inglês | MEDLINE | ID: mdl-15043998

RESUMO

Tyrosine nitration of proteins is emerging as a post-translational modification playing a role in physiological conditions. Looking for the molecular events triggered by nitric oxide in nerve growth factor-induced neuronal differentiation, we now find that nitration occurs on the microtubule-associated protein tau. In differentiated PC12 cells, we have identified as tau a nitrated protein that co-immunoprecipitates with alpha-tubulin and indicated that the modified protein is associated with the cytoskeleton but it is confined to a restricted cell region. This paper supplies the first evidence that nitration of tau occurs in a physiological process and suggests that it could play a role in neuronal differentiation.


Assuntos
Neurônios/metabolismo , Óxido Nítrico/metabolismo , Tirosina/análogos & derivados , Proteínas tau/metabolismo , Sequência de Aminoácidos , Animais , Citoesqueleto/metabolismo , Humanos , Dados de Sequência Molecular , Neurônios/citologia , Células PC12 , Peptídeos/química , Peptídeos/metabolismo , Ratos , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz , Tirosina/metabolismo , Proteínas tau/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA